Equities research analysts expect that Agilent Technologies, Inc. (NYSE:A) will report $0.58 earnings per share (EPS) for the current quarter, Zacks reports. Seven analysts have issued estimates for Agilent Technologies’ earnings. The highest EPS estimate is $0.62 and the lowest is $0.57. Agilent Technologies reported earnings of $0.53 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 9.4%. The firm is expected to issue its next earnings results on Tuesday, February 13th.

According to Zacks, analysts expect that Agilent Technologies will report full-year earnings of $2.58 per share for the current financial year, with EPS estimates ranging from $2.53 to $2.68. For the next financial year, analysts forecast that the business will post earnings of $2.86 per share, with EPS estimates ranging from $2.77 to $2.96. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that follow Agilent Technologies.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.96%. The business had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter last year, the company earned $0.59 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year.

A number of analysts recently weighed in on A shares. Jefferies Group reaffirmed a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a report on Wednesday, August 9th. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price objective on the stock in a report on Tuesday, October 31st. Robert W. Baird reaffirmed a “buy” rating and issued a $70.00 price objective on shares of Agilent Technologies in a report on Friday, October 20th. Janney Montgomery Scott increased their price objective on shares of Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a report on Wednesday, August 16th. Finally, Cowen reaffirmed a “hold” rating and issued a $70.00 price objective on shares of Agilent Technologies in a report on Wednesday, November 22nd. Six investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $68.34.

Agilent Technologies (NYSE A) traded down $0.55 during mid-day trading on Friday, hitting $68.69. 2,516,520 shares of the company were exchanged, compared to its average volume of 1,938,537. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30. Agilent Technologies has a 1-year low of $43.27 and a 1-year high of $70.93. The firm has a market cap of $22,283.37, a PE ratio of 29.22, a PEG ratio of 2.09 and a beta of 1.27.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.149 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. The ex-dividend date is Friday, December 29th. This represents a $0.60 annualized dividend and a dividend yield of 0.87%. Agilent Technologies’s dividend payout ratio (DPR) is 25.24%.

In other Agilent Technologies news, SVP Jacob Thaysen sold 22,583 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $70.41, for a total value of $1,590,069.03. Following the completion of the transaction, the senior vice president now directly owns 63,042 shares in the company, valued at $4,438,787.22. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Didier Hirsch sold 1,200 shares of the firm’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $66.00, for a total transaction of $79,200.00. Following the completion of the transaction, the chief financial officer now owns 164,202 shares of the company’s stock, valued at $10,837,332. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 151,114 shares of company stock valued at $10,359,388.

Institutional investors and hedge funds have recently made changes to their positions in the business. Jennison Associates LLC acquired a new position in shares of Agilent Technologies in the second quarter worth about $212,000. Commerce Bank acquired a new stake in shares of Agilent Technologies during the second quarter worth approximately $1,242,000. Delta Lloyd Asset Management N.V. acquired a new stake in shares of Agilent Technologies during the second quarter worth approximately $2,026,000. Prudential Financial Inc. boosted its holdings in shares of Agilent Technologies by 2.5% during the second quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock worth $27,134,000 after purchasing an additional 11,020 shares during the period. Finally, Cipher Capital LP boosted its holdings in shares of Agilent Technologies by 18.1% during the second quarter. Cipher Capital LP now owns 89,523 shares of the medical research company’s stock worth $5,309,000 after purchasing an additional 13,703 shares during the period.

TRADEMARK VIOLATION NOTICE: This article was first published by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.dailypolitical.com/2017/12/02/brokerages-anticipate-agilent-technologies-inc-a-will-post-earnings-of-0-58-per-share.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Get a free copy of the Zacks research report on Agilent Technologies (A)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.